Deletion of CCR1 Attenuates Pathophysiologic Responses during Respiratory Syncytial Virus Infection

The role of chemokines in chronic inflammatory responses are central to the recruitment of particular subsets of leukocytes. In the present studies, we have examined the role of CCR1 in the developing pathogenesis of respiratory syncytial virus (RSV) in the lungs of infected BALB/c mice. Although we did not observe significant differences in clearance of RSV, we were able to identify decreased pathophysiologic responses in CCR1−/− mice. CCR1−/− mice displayed a significant reduction in both airway hyperresponsiveness and mucus production that corresponded to significant increases in IFN-γ and CXCL10. The goblet cell hyper/metaplasia and the expression of mucus-associated gene, gob5, were correspondingly reduced in the CCR1−/− mice. In addition, the Western blot analysis of gob5 protein indicated that CCR1−/− mice have virtually no up-regulation of the protein at day 6 of infection compared with wild-type-infected mice. Results from bone marrow chimeric mice indicated that partial reconstitution of the response could be achieved in the CCR1−/− mice with wild-type bone marrow cells, suggesting that these cells have a role in the response. However, transplanting of CCR1−/− bone marrow into wild-type mice did demonstrate an incomplete deficit in RSV-induced responses, indicating that CCR1+ parenchymal cells may also play a significant role in the process. Thus, the presence of CCR1 appears to have a significant role in the development of detrimental airway physiologic responses during RSV infection. These data suggest that CCR1 may be a potential target during detrimental pulmonary responses during infection.

[1]  C. Duckett,et al.  Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression , 2005, Journal of Virology.

[2]  M. Schaller,et al.  Respiratory syncytial virus‐induced exaggeration of allergic airway disease is dependent upon CCR1‐associated immune responses , 2005, European journal of immunology.

[3]  B. Graham,et al.  Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. , 2004, American journal of respiratory and critical care medicine.

[4]  N. Lukacs,et al.  Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.

[5]  E. Gelfand,et al.  Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen. , 2003, The Journal of allergy and clinical immunology.

[6]  P. Tak,et al.  Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[7]  K. Harrod,et al.  Clara Cell Secretory Protein Modulates Lung Inflammatory and Immune Responses to Respiratory Syncytial Virus Infection1 , 2003, The Journal of Immunology.

[8]  N. Lukacs,et al.  Respiratory syncytial virus‐induced CCL5/RANTES contributes to exacerbation of allergic airway inflammation , 2003, European journal of immunology.

[9]  A. Naya,et al.  CCR1 chemokine receptor antagonist. , 2003, Current pharmaceutical design.

[10]  A. Gruber,et al.  CXCR2 Regulates Respiratory Syncytial Virus-Induced Airway Hyperreactivity and Mucus Overproduction1 , 2003, The Journal of Immunology.

[11]  R. Welliver Respiratory syncytial virus and other respiratory viruses , 2003, The Pediatric infectious disease journal.

[12]  F. Martinez Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma , 2003, The Pediatric infectious disease journal.

[13]  R. Lemanske The Childhood Origins of Asthma (COAST) study , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[14]  S. Kunkel,et al.  RANTES (CCL5) production during primary respiratory syncytial virus infection exacerbates airway disease , 2002, European journal of immunology.

[15]  B. Graham,et al.  The Role of IFN in Respiratory Syncytial Virus Pathogenesis , 2002, The Journal of Immunology.

[16]  M. Koss,et al.  Bronchiolitis: update 2001. , 2002, Current opinion in pulmonary medicine.

[17]  E. Raz,et al.  Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretion. , 2001, The Journal of allergy and clinical immunology.

[18]  Prince Am,et al.  Prevention of respiratory syncytial virus infection in high risk infants. , 2001, The Journal of the Arkansas Medical Society.

[19]  R. Garofalo,et al.  Macrophage Inflammatory Protein-1α (Not T Helper Type 2 Cytokines) Is Associated with Severe Forms of Respiratory Syncytial Virus Bronchiolitis , 2001 .

[20]  M. Kaplan,et al.  Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. , 2001, The American journal of pathology.

[21]  L. O’Neill Gob genes, mucus and asthma. , 2001, Trends in immunology.

[22]  W. Heath Motility is more important that stealth , 2001 .

[23]  Yukio Fujisawa,et al.  Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Garofalo,et al.  Inducible Expression of Inflammatory Chemokines in Respiratory Syncytial Virus-Infected Mice: Role of MIP-1α in Lung Pathology , 2001, Journal of Virology.

[25]  P. Openshaw,et al.  IL-12-Activated NK Cells Reduce Lung Eosinophilia to the Attachment Protein of Respiratory Syncytial Virus But Do Not Enhance the Severity of Illness in CD8 T Cell-Immunodeficient Conditions1 , 2000, The Journal of Immunology.

[26]  H. Rosenberg,et al.  MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. , 2000, Cellular immunology.

[27]  H. Popper Bronchiolitis, an update , 2000, Virchows Archiv.

[28]  T. Noah,et al.  Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. , 2000, Clinical immunology.

[29]  B. Graham,et al.  Immune-mediated disease pathogenesis in respiratory syncytial virus infection. , 2000, Immunopharmacology.

[30]  R. Lockey,et al.  Recurrent Respiratory Syncytial Virus Infections in Allergen-Sensitized Mice Lead to Persistent Airway Inflammation and Hyperresponsiveness1 , 2000, The Journal of Immunology.

[31]  R. Horuk,et al.  Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor. , 2000, European journal of pharmacology.

[32]  J. Cyster,et al.  Leukocyte migration: Scent of the T zone , 2000, Current Biology.

[33]  R. Lockey,et al.  Intranasal IFN-γ gene transfer protects BALB/c mice against respiratory syncytial virus infection , 1999 .

[34]  T. Braciale,et al.  Induction of Th-1 and Th-2 Responses by Respiratory Syncytial Virus Attachment Glycoprotein Is Epitope and Major Histocompatibility Complex Independent , 1999, Journal of Virology.

[35]  H. Rosenberg,et al.  Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. , 1999, American journal of respiratory and critical care medicine.

[36]  E. Gelfand,et al.  IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. , 1999, Journal of immunology.

[37]  H. Rosenberg,et al.  Macrophage inflammatory protein‐1α and RANTES are present in nasal secretions during ongoing upper respiratory tract infection , 1999 .

[38]  R. Strieter,et al.  Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. , 1998, Journal of immunology.

[39]  J. Westwick,et al.  Chemokines: understanding their role in T-lymphocyte biology. , 1998, The Biochemical journal.

[40]  J. Friedland,et al.  Respiratory Syncytial Virus-Induced RANTES Production from Human Bronchial Epithelial Cells Is Dependent on Nuclear Factor-κB Nuclear Binding and Is Inhibited by Adenovirus-Mediated Expression of Inhibitor of κBα , 1998, The Journal of Immunology.

[41]  R. Garofalo,et al.  Cell-Specific Expression of RANTES, MCP-1, and MIP-1α by Lower Airway Epithelial Cells and Eosinophils Infected with Respiratory Syncytial Virus , 1998, Journal of Virology.

[42]  A. Saluja,et al.  Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. , 1997, The Journal of clinical investigation.

[43]  B. Graham,et al.  T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. , 1997, The Journal of clinical investigation.

[44]  T. Noah,et al.  RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES. , 1997, The American journal of physiology.

[45]  R. Garofalo,et al.  Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. , 1997, The Journal of infectious diseases.

[46]  B. Graham,et al.  Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. , 1995, The Journal of infectious diseases.

[47]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.